Jong Joseph Kim - Mar 11, 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Chief Executive Officer, Director
Signature
/s/ Jong Joseph Kim
Stock symbol
INO
Transactions as of
Mar 11, 2022
Transactions value $
-$127,828
Form type
4
Date filed
3/14/2022, 04:36 PM
Previous filing
Mar 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +139K +10.54% 1.46M Mar 11, 2022 Direct F1
transaction INO Common Stock Tax liability -$128K -39.7K -2.71% $3.22* 1.42M Mar 11, 2022 Direct F2
holding INO Common Stock 817K Mar 11, 2022 By Family Limited Partnership
holding INO Common Stock 33.6K Mar 11, 2022 By Daughter: EK
holding INO Common Stock 33.8K Mar 11, 2022 By Son: JK1
holding INO Common Stock 5.98K Mar 11, 2022 By Spouse
holding INO Common Stock 33.5K Mar 11, 2022 By Son: JK2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -139K -50% $0.00 139K Mar 11, 2022 Common Stock 139K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares vested on March 11, 2021; 139,387 shares vested on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.